II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound semiconductor epitaxial and gallium arsenide wafers.
Read More…
Industry, Sector and Symbol
Industry Optical instruments & lenses
Sub-IndustryElectrical Components & Equipment
SectorIndustrial Products
Phone724-352-4455
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.36 billion
Profitability
Miscellaneous
Employees12,487
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
II-VI (NASDAQ:IIVI) Frequently Asked Questions
What is II-VI's stock symbol?
II-VI trades on the NASDAQ under the ticker symbol "IIVI."
How were II-VI's earnings last quarter?
II-VI, Inc. (NASDAQ:IIVI) released its earnings results on Tuesday, August, 13th. The scientific and technical instruments company reported $0.67 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.29. The scientific and technical instruments company earned $362.70 million during the quarter, compared to analyst estimates of $348.02 million. II-VI had a return on equity of 10.37% and a net margin of 7.89%. II-VI's revenue for the quarter was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.52 EPS. View II-VI's Earnings History.
When is II-VI's next earnings date?
What guidance has II-VI issued on next quarter's earnings?
II-VI updated its first quarter earnings guidance on Tuesday, August, 13th. The company provided earnings per share guidance of $0.55-0.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.65. The company issued revenue guidance of $320-345 million, compared to the consensus revenue estimate of $348.16 million.
What price target have analysts set for IIVI?
11 Wall Street analysts have issued 12 month target prices for II-VI's stock. Their forecasts range from $31.00 to $53.00. On average, they expect II-VI's share price to reach $44.60 in the next twelve months. This suggests a possible upside of 39.0% from the stock's current price. View Analyst Price Targets for II-VI.
What is the consensus analysts' recommendation for II-VI?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for II-VI in the last year. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for II-VI.
What are Wall Street analysts saying about II-VI stock?
Here are some recent quotes from research analysts about II-VI stock:
- 1. Northland Securities analysts commented, "We are lowering our FY20 ests and lower our PT slightly on a mixed FQ4 report and outlook Tues AM from IIVI, though we maintain our OP rating focused on the synergy potential of the FNSR deal, which the company now hopes to close in the Fall". Stand alone, optical strength, bolstered by a $15M pull in from FQ1, continues albeit with slower order growth, while book to bills in Laser Solutions, despite expectations for a strong 3DS ramp in Products were very weak." (8/14/2019)
- 2. According to Zacks Investment Research, "II-VI Incorporated designs, manufactures and markets optical and opto-electronic components, devices and materials for infrared, near-infrared, visible light, x-ray and gamma ray instrumentation. The Company's infrared optics business manufactures optical and opto-electronic components sold under the II-VI brand name and used primarily in CO2 lasers. The Company's near-infrared optics business manufactures near-infrared & visible light products for industrial, scientific, military & medical instruments and laser gain materials and products for solid-state YAG and YLF lasers at the Company's VLOC subsidiary. The Company's military infrared optics business manufactures infrared products for military applications under the Exotic Electro-Optics brand name. " (8/2/2019)
Has II-VI been receiving favorable news coverage?
News coverage about IIVI stock has trended very negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. II-VI earned a news sentiment score of -3.8 on InfoTrie's scale. They also assigned media stories about the scientific and technical instruments company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for II-VI.
Who are some of II-VI's key competitors?
What other stocks do shareholders of II-VI own?
Who are II-VI's key executives?
II-VI's management team includes the folowing people:
- Dr. Vincent D. Mattera Jr., Pres, CEO & Director (Age 63)
- Ms. Mary Jane Raymond, CFO, Treasurer & Assistant Sec. (Age 59)
- Mr. Gary Alan Kapusta, Chief Operating Officer (Age 59)
- Dr. Giovanni Barbarossa, CTO & Pres of Laser Solutions Segment (Age 59)
- Ms. Jo Anne Schwendinger, Chief Legal & Compliance Officer and Sec. (Age 64)
Who are II-VI's major shareholders?
II-VI's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Scout Investments Inc. (0.38%) and State of Alaska Department of Revenue (0.06%). Company insiders that own II-VI stock include Christopher Koeppen, David G Wagner, Francis J Kramer, Howard H Xia, Joseph J Corasanti, Marc Y E Pelaez, Mary Jane Raymond, Shaker Sadasivam and Vincent D Mattera Jr. View Institutional Ownership Trends for II-VI.
Which institutional investors are selling II-VI stock?
IIVI stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc.. Company insiders that have sold II-VI company stock in the last year include Christopher Koeppen, David G Wagner, Francis J Kramer, Marc Y E Pelaez, Mary Jane Raymond and Vincent D Mattera Jr. View Insider Buying and Selling for II-VI.
Which institutional investors are buying II-VI stock?
IIVI stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have bought II-VI stock in the last two years include Joseph J Corasanti and Shaker Sadasivam. View Insider Buying and Selling for II-VI.
How do I buy shares of II-VI?
Shares of IIVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is II-VI's stock price today?
One share of IIVI stock can currently be purchased for approximately $32.10.
How big of a company is II-VI?
II-VI has a market capitalization of $2.07 billion and generates $1.36 billion in revenue each year. The scientific and technical instruments company earns $107.52 million in net income (profit) each year or $1.63 on an earnings per share basis. II-VI employs 12,487 workers across the globe.View Additional Information About II-VI.
What is II-VI's official website?
How can I contact II-VI?
II-VI's mailing address is 375 SAXONBURG BLVD, SAXONBURG PA, 16056. The scientific and technical instruments company can be reached via phone at 724-352-4455 or via email at [email protected]
MarketBeat Community Rating for II-VI (NASDAQ IIVI)
MarketBeat's community ratings are surveys of what our community members think about II-VI and other stocks. Vote "Outperform" if you believe IIVI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IIVI will underperform the S&P 500 over the long term. You may vote once every thirty days.
